Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study
Glucagon receptor increases hepatic glucose output acutely but, under chronic agonism, raises basal energy expenditure and promotes hepatic lipid oxidation
The commentary concluded that, based on current knowledge, patients should not stop taking semaglutide on this account alone, especially given potential increases in morbidity from conditions that are well controlled by semaglutide, potential adverse effects of hyperglycemia caused by abrupt cessation of treatment, and the seemingly low absolute risk of NAION
The first step was a survey that took four minutes to complete
However, recent guidelines now recommend a more flexible approach, especially for patients with cardiovascular disease or high-risk profiles